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Abstract 
Background: The purpose of this study was to analyze the effects and results 
of dimethyl sulfoxide (DMSO) usage on viability and perfusion of local and 
regional flaps in rabbits, via this study we are going to conclude whether DMSO 
could be effective after flap operations in human or not.  
Materials and Methods: Local and regional DMSO spray was used on 
rabbit’s dorsum flaps immediately after the operation and once per day up to 7 
days post-op in 14 rabbits, divided equally to control group (saline solution 
spray) or experiment group (DMSO spray). The results were compared 3 and 7 
days after operations.  
Results: There were improved results attributed to the DMSO effects 
regarding flap survival  
Conclusion: We concluded that topical application of DMSO reduces skin flap 
ischemia in rabbits and we highly advise the use of it after operations in which 
skin flaps are created.  
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Introduction 
Tissue circulation has been a favorite for plastic 
surgeons, especially due to its role in decreasing the 
chance of tissue flap ischemia. In several studies, 
following abdominoplasty and facelift operations 
topical Dimethyl sulfoxide (DMSO), have improved 
chances of success to increase skin perfusion; so they 
have advised DMSO in procedures with risks for 
ischemia (1-3). DMSO has several applications in 
medicine and also, in industry. Though controversial, 
using DMSO in flaps has been quoted frequently; 
however, the last word is to be said yet (4, 5). 
Furthermore, the mechanism of DMSO action 
rarely has been discovered;  the role of DMSO in tissue 
histamine release has been quoted by some authors, 
leading to vasodilation of flap vessels. Different use 
forms of DMSO (injectable, topical, intravenous) have 
been studied on animal and human models (6). 
This experimental study was performed on rat 
tissue flaps to assess the role of perioperative local 
DMSO  on cellular and tissue viability (7-9). 
 
Methods 
The study protocol was assessed and approved by the 
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University of Medical Sciences (IRB Ethics Code: 
IR.SBMU.RETECH.REC. 1399.262; June 30, 2020). 
This study was performed in the animal lab, 15 
Khordad Center (a referral hospital dedicated to plastic 
and reconstructive surgery affiliated to the Shahid 
Beheshti University of Medical Science). 
To investigate the efficacy of perioperative 
application of DMSO on regional and local flaps 
viability, we designed an experimental study, 
consisting of 14 rabbits, of which seven were allocated 
to the control group (just Saline solution sprayed on the 
tissue); however, the other group included 7 rabbits, 
which received DMSO spray on the tissue cells. We 
used DMSO spray-on local and regional flaps in 
rabbits’ dorsum immediately after an operation and 
once per day up to 7 days postop.  
In the next study step, we cut elevated cutaneous 
flaps with diameters about 8*2 cm on the dorsum of 
each rabbit and sutured it again; afterward, we 
followed up the flaps by applying saline in one group 
and DMSO in another group, with especial concern on 
ecchymosis, edema, and necrosis. Topical DMSO with 
a density of 60% in combination with 10% urea and 
30% water was applied for skin flaps in examined 
group 3 times per day up to 7 days; whereas in the 
control group, we applied saline on the skin flaps 
similarly. Therefore, we examined flaps every day till 
1 week regarding flap perfusion, color, and secretion 
around flaps. 
Allocation of the animals to each of the study 
groups was performed using a random table of 
numbers. All steps in the application of DMSO and 
saline were performed by just one of the members of 
the team; while, all the perioperative assessments were 
performed by another member of the team who was 
unaware of the study group. The post-op status of the 
flaps was compared using the Chi-square test. All 
statistical analyses were performed by SPSS; while a 




In our study, we compared the results of two groups 
after 7 days of applying DMSO for examined group 
and saline in the control group. Among 7 rabbits in the 
examined group, just 1 of them had necrosis around the 
flap on 3th day and also infected flap in this case; 
however, the rest of them had viable flaps. Meanwhile, 
among the other 7 rabbits in the control group, 3 rabbits 
had flap necrosis after 3 days of surgery, which one 
infected rabbit was observed. So the survival of flaps 
in the examined group was 86% in comparison with 
57% in the control group (P value<0.05). In each 
group, only one case of infection (odor, secretion, and 
erythema) was observed (15%); demonstrating no 
significant difference between the two groups. Also, no 




In our study, the use of DMSO 60% decreased 
ischemic flaps in the examined group (86%), the 
results in our study are considered similar to the results 
of other previous studies which had applied topical 
DMSO with a variety of concentrations from 50% to 
95%. More knowledge about skin circulation and 
physiology causes surgeons to perform the best 
methods and technics for surviving microscopic 
anastomosis of flaps and prevent flap necrosis, 
especially considering the role of cellular and 
molecular mechanisms of organ protection and the 
potential role of DMSO (10). 
The previous studies have shown that the ability 
of DMSO to cross all membranes varies according to 
DMSO strength. The most effective DMSO strength 
for penetrating the skin is a solution between 70-90%. 
For reasons unknown, concentrations higher than 90% 
are less effective. Much lower concentrations of 
DMSO -in the range of 1% to 8%- are sufficient for 
crossing membranes other than skin. McFarlen et al 
(1968) reported the DMSO effect on preventing 
experimental pedicle flaps. One study of abdominal 
island flaps in rats compared control animals that 
received saline injections with rats injected with 
intraperitoneal DMSO. Flaps in the treatment group 
showed significantly increased blood perfusion by 
postoperative day 3 as measured by laser velocimetry 
and perfusion fluorometry (11-12). 
In another study on rats, 9*4 cm pedicle 
abdominal flaps were assessed. Occlusion of the 
epigastric vein was done for 8 hours and then, the flap 
was resutured to its bed. Two groups received 
The Effect of Perioperative Dimethyl Sulfoxide Efficacy on Regional and Local Flaps Viability                    Shahrokh et al. 
Vol 6, No 1, Winter 2021 
91 
intraperitoneal saline; while three others received 
intraperitoneal DMSO at different time points:  
 only reperfusion time 
 at reperfusion time and then every day for 5 days 
 before the operation, at operation, and till 5 days 
after the operation.  
A sonic digitizer was used for the assessment of results 
(flap survival). Two groups that received DMSO at 
reperfusion and 5 days after surgery had better 
outcomes regarding flap survival (13). 
In one study topical DMSO efficacy was 
examined on 10* 2.5 cm elevated and resutured flaps 
of rabbit dorsum, as 4 groups: 
 saline control group 
 DMSO 50% treated group 
 H2O2 8% treated group 
 DMSO and H2O2 treated group.  
 
Flap survival was compared using planimetry 7 days 
after surgery. There were no differences among the 
groups' survival that received saline, H2O2, or DMSO 
alone; however, flaps treated with DMSO+H2O2 had 
a greater area of survival; also, the PtcO2 amount had 
improved for the DMSO+H2O2 group (14).  
Rand Luby et al performed prospective research 
for skin flap viability in patients who had undergone a 
mastectomy, using topical 60% DMSO. The mean area 
of ischemia for the DMSO group was significantly 
smaller than the control group (15). 
Rasposio and Santi performed a study on 40 
patients who had undertaken immediate breast 
reconstruction (tissue expansion) following 
mastectomy. Twenty patients had standard tissue 
expansion while another 20 patients received DMSO 
60% sponges on the skin overlying the expander 30 
minutes before the expansion. A significant difference 
was found in the number of expander filling sessions 
and the mean inflated volume for each session (16). 
Vinnik had a study on mastectomy patients, 
which applied topical DMSO immediately after 
placement of large permanent expanders; they 
observed great results after surgeries. Similar results 
regarding flaps perfusion were seen in patients under 
abdominoplasty (17). 
Different types of free radicals are mediators for 
cell damages and are produced in ischemic or 
reperfused tissues due to the structure of DMSO 
(Figure 1); on the other hand, DMSO has a proper 
structure in oxidizing and scavenging free radicals, and 
theoretically, DMSO could be effective in scavenging 
free radicals in skin and island flaps, leading to 
increased flap survival. However, the main drawbacks 
of DMSO are: 
 hemolysis after intravenous use (less than 2g/Kg) 
and rapid injection of it (30 min>) (18) 
 chance of ophthalmologic toxicity (18, 19)  
 DMSO could penetrate from the Stratum Corneum 
(upper layer of skin) and it performs as a carrier, 
which also, increases the substances penetrations 
(20-22) 
 some studies have cited the potential effects of 
DMSO regarding its effects on cellular proteomics, 
epigenomics, and microRNAs; which might affect 
the role of cell fate in its future life (23, 24) 
 
Conclusion 
In our study, we observed significant results after 
topical DMSO 60% on skin flaps, which had a 
substantial impact on reducing tissue damages due to 
loss of perfusion and surgery trauma. Based on the 
results of this study we suggest that topical DMSO is 
an appropriate and effective solution for the protection 
of cutaneous flaps in the perioperative period; a result 
supported by prior researches.  
It is considered wise to apply DMSO on 
cutaneous or pedunculated flaps while other traditional 
methods for flap perfusions such as tension releases on 
the pedicle, decrease kinks, and remove load pressure 
on flaps have been defeated. By appearing some signs 
of ischemia in flaps, topical DMSO might be effective 
to improve tissue perfusion. This product is not 
expensive and could be reachable for patients at home, 
 
Figure 1. chemical formulation of Dimethyl sulfoxide 
(DMSO). 
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even though it cannot repair necrosis areas of flaps and 
recur the circulation of these regions; though some 
controversies exist (7-9, 23, 24). More sophisticated 
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